Complementing Observational Signals with Literature-Derived Distributed Representations for Post-Marketing Drug Surveillance

被引：0
|
作者：
Justin Mower
Trevor Cohen
Devika Subramanian
机构：
[1] Rice University,Department of Computer Science
[2] University of Washington,undefined
[3] Biomedical Informatics and Medical Education,undefined
来源：
Drug Safety | 2020年 / 43卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：67 / 77
页数：10
相关论文
共 50 条
  • [21] A Systematic Literature Review of the Determinants of Signal Detection In Post-Marketing Surveillance Systems
    G. L. Ferreira
    S. S. Shakir
    D. Brown
    Drug Safety, 2008, 31 : 885 - 885
  • [22] A Systematic Literature Review of the Determinants of Signal Detection In Post-Marketing Surveillance Systems
    Ferreira, G. L.
    Shakir, S. S.
    Brown, D.
    DRUG SAFETY, 2008, 31 (10) : 899 - 899
  • [23] Post-marketing drug safety surveillance of enfortumab vedotin: an observational pharmacovigilance study based on a real-world database
    Yu, Mingming
    Zhou, Lijun
    Cao, Mengda
    Ji, Chunmei
    Zheng, Yuanyi
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [24] Post-marketing safety surveillance of fostamatinib: an observational, pharmacovigilance study leveraging FAERS database
    Wei, Wei
    Bai, Ying-Tao
    Chang, En
    Liu, Jin-Feng
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [25] A Clustering Ensemble Method for Drug Safety Signal Detection in Post-Marketing Surveillance
    Chakraborty, Shubhadeep
    Tiwari, Ram
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2025, 59 (01) : 89 - 101
  • [26] INFORMATION-SYSTEM FOR POST-MARKETING DRUG SURVEILLANCE SCHEME ON SMALL COMPUTERS
    MOUSSA, MAA
    METHODS OF INFORMATION IN MEDICINE, 1982, 21 (04) : 181 - 186
  • [27] Utility of electronic health records to support post-marketing drug safety surveillance
    Lin, Nancy D.
    Calderbank, Jenna
    Anderson, David
    Seeger, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 415 - 415
  • [28] Drug-induced Neuropsychiatric Adverse Events Using Post-Marketing Surveillance
    Wakabayashi, Tomohito
    Nakatsuji, Takahiro
    Kambara, Hiroko
    Niinomi, Iku
    Oyama, Saki
    Inada, Ayaka
    Ueno, Sayaka
    Uchida, Mayako
    Iwanaga, Kazunori
    Iida, Tatsuya
    Hosohata, Keiko
    CURRENT REVIEWS IN CLINICAL AND EXPERIMENTAL PHARMACOLOGY, 2022, 17 (02) : 144 - 148
  • [29] Role of the Post-Marketing Authorisation Studies in Drug Risk Surveillance: Specifications and Methodologies
    Tubach, Florence
    Lamarque-Garnier, Veronique
    Castot, Anne
    THERAPIE, 2011, 66 (04): : 355 - 362
  • [30] A Temporal Interestingness Measure for Drug Interaction Signal Detection in Post-marketing Surveillance
    Ji, Yanqing
    Ying, Hao
    Tran, John
    Dews, Peter
    Mansour, Ayman
    Massanari, R. Michael
    2014 36TH ANNUAL INTERNATIONAL CONFERENCE OF THE IEEE ENGINEERING IN MEDICINE AND BIOLOGY SOCIETY (EMBC), 2014, : 2722 - 2725
12345